Positive Results from Pivotal Trial of Better Therapeutics' Investigational BT-001 Prescription Digital Therapy for Type 2 Diabetes Published in Diabetes Care – Business Wire
ADA-published, peer-reviewed journal article highlights positive primary endpoint data from trial evaluating digitally delivered approach to diabetes management SAN FRANCISCO–(BUSINESS WIRE)–Better Therapeutics, Inc. (NASDAQ: BTTX), a prescription digital therapeutics (PDT)…